SECUKINUMAB IN GIANT CELL ARTERITIS: THE RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE PHASE 2 TITAIN TRIAL

被引：6

作者：

Venhoff, N. ^{[1
]}

Schmidt, W. A. ^{[2
]}

Bergner, R. ^{[3
]}

Rech, J. ^{[4
]}

Unger, L. ^{[5
]}

Tony, H. P. ^{[6
]}

Mendelson, M. ^{[7
]}

Sieder, C. ^{[8
]}

Maricos, M. ^{[8
]}

Thiel, J. ^{[1
,9
]}

机构：

[1] Univ Freiburg, Vasculitis Ctr Freiburg, Dept Rheumatol & Clin Immunol, Med Ctr, Freiburg, Germany

[2] Med Ctr Rheumatol Berlin Buch, Immanuel Krankenhaus Berlin, Berlin, Germany

[3] Klinikum Stadt Ludwigshafen, Med Klin, Ludwigshafen, Germany

[4] Friedrich Alexander Univ FAU Erlangen Nurnberg, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany

[5] Stadt Klinikum Dresden, Med Dept 1, Dresden, Germany

[6] Rheumatol & Clin Immunol Oberduerrbachertstr, Dept Med 2, Wurzburg, Germany

[7] Novartis Pharmaceut, Rheumatol, Newark, NJ USA

[8] Novartis Pharma GmbH, Rheumatol, Nurnberg, Germany

[9] Med Univ Graz, Div Rheumatol & Immunol, Dept Internal Med, Graz, Austria

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷

关键词：

D O I：

10.1136/annrheumdis-2022-eular.806

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0182

引用

页码：121 / 122

页数：2

共 50 条

[1] Secukinumab in Giant Cell Arteritis: A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase 2 Trial
Venhoff, Nils
Schmidt, Wolfgang
Bergner, Raoul
Rech, Juergen
Unger, Leonore
Tony, Hans-Peter
Mendelson, Meryl
Sieder, Christian
Maricos, Meron
Thiel, Jens
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4130 - 4133
[2] Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo- controlled, phase 2 trial
Venhoff, Nils
Schmidt, Wolfgang A.
Bergner, Raoul
Rech, Juergen
Unger, Leonore
Tony, Hans -Peter
Finzel, Stephanie
Andreica, Ioana
Kofler, David M.
Weiner, Stefan M.
Lamprecht, Peter
Schulze-Koops, Hendrik
App, Christine
Pournara, Effie
Mendelson, Meryl H.
Sieder, Christian
Maricos, Meron
Thiel, Jens
LANCET RHEUMATOLOGY, 2023, 5 (06): : e341 - e350
[3] A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis
Schmidt, Wolfgang A.
Dasgupta, Bhaskar
Luqmani, Raashid
Unizony, Sebastian H.
Blockmans, Daniel
Lai, Zhihong
Kurrasch, Regina H.
Lazic, Ivana
Brown, Kurt
Rao, Ravi
RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 793 - 810
[4] A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis
Wolfgang A. Schmidt
Bhaskar Dasgupta
Raashid Luqmani
Sebastian H. Unizony
Daniel Blockmans
Zhihong Lai
Regina H. Kurrasch
Ivana Lazic
Kurt Brown
Ravi Rao
Rheumatology and Therapy, 2020, 7 : 793 - 810
[5] Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
Cid, Maria C.
Unizony, Sebastian H.
Blockmans, Daniel
Brouwer, Elisabeth
Dagna, Lorenzo
Dasgupta, Bhaskar
Hellmich, Bernhard
Molloy, Eamonn
Salvarani, Carlo
Trapnell, Bruce C.
Warrington, Kenneth J.
Wicks, Ian
Samant, Manoj
Zhou, Teresa
Pupim, Lara
Paolini, John F.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (05) : 653 - 661
[6] Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial
Venhoff, Nils
Schmidt, Wolfgang A.
Lamprecht, Peter
Tony, Hans-Peter
App, Christine
Sieder, Christian
Legeler, Carolin
Jentzsch, Claudia
Thiel, Jens
TRIALS, 2021, 22 (01)
[7] Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial
Nils Venhoff
Wolfgang A. Schmidt
Peter Lamprecht
Hans-Peter Tony
Christine App
Christian Sieder
Carolin Legeler
Claudia Jentzsch
Jens Thiel
Trials, 22
[8] Phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study of ustekinumab in patients with Takayasu arteritis
Yoshifuji, Hajime
Ishii, Tomonori
Ohashi, Hiroki
Yoshizawa, Katsunori
Mihoya, Maki
Nishikawa, Kazuko
Nakaoka, Yoshikazu
RHEUMATOLOGY ADVANCES IN PRACTICE, 2025, 9 (02)
[9] Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
Villiger, Peter M.
Adler, Sabine
Kuchen, Stefan
Wermelinger, Felix
Dan, Diana
Fiege, Veronika
Butikofer, Lukas
Seitz, Michael
Reichenbach, Stephan
LANCET, 2016, 387 (10031): : 1921 - 1927
[10] Tocilizumab for Induction and Maintenance of Remission in Giant Cell Arteritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial
Lunzer, R.
JOURNAL FUR MINERALSTOFFWECHSEL & MUSKULOSKELETTALE ERKRANKUNGEN, 2016, 23 (02): : 60 - 60

← 1 2 3 4 5 →